Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
Marco Bezzi1, Nina Seitzer1, Tomoki Ishikawa1
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
Multiple immune-cell types can infiltrate tumors and promote progression and metastasis through different mechanisms, including immunosuppression. How distinct genetic alterations in tumors affect the composition of the immune landscape is currently unclear. Here, we characterized the immune-cell composition of prostate cancers driven by the loss of the critical tumor suppressor gene Pten, either alone or in combination with the loss of Trp53, Zbtb7a or Pml. We observed a striking quantitative and qualitative heterogeneity that was directly dependent on the specific genetic events in the tumor and ranged from 'cold', noninflamed tumors to massively infiltrated landscapes-results with important therapeutic implications. Further, we showed these qualitative differences in transcriptomic analysis of human prostate cancer samples. These data suggest that patient stratification on the basis of integrated genotypic-immunophenotypic analyses may be necessary for successful clinical trials and tailored precision immunological therapies.
Insights
Tumor genetics significantly alter immune cell infiltration in prostate cancer. Understanding these immune landscapes is crucial for developing effective precision immunotherapies.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Tumor-infiltrating immune cells play complex roles in cancer progression and metastasis.
- The relationship between specific genetic alterations in tumors and the tumor immune microenvironment is not well understood.
Purpose of the Study:
- To investigate how distinct genetic alterations, specifically the loss of tumor suppressor genes Pten, Trp53, Zbtb7a, or Pml, affect immune cell composition in prostate cancer.
- To correlate genotypic profiles with immunophenotypic characteristics in prostate cancer.
Main Methods:
- Characterization of immune-cell composition in prostate cancer models with specific genetic losses.
- Transcriptomic analysis of human prostate cancer samples to identify genotype-immunophenotype correlations.
Main Results:
- Observed significant quantitative and qualitative heterogeneity in immune cell infiltration, directly dependent on specific genetic events.
- Demonstrated a spectrum from 'cold' (non-inflamed) to 'hot' (massively infiltrated) immune landscapes based on genetic alterations.
- Confirmed these genotype-dependent immune landscape differences through transcriptomic analysis of human samples.
Conclusions:
- Specific genetic alterations in prostate cancer dictate distinct immune cell compositions.
- Integrated genotypic and immunophenotypic analyses are essential for patient stratification in clinical trials.
- Tailored precision immunotherapies may require consideration of the tumor's genetic background and resulting immune landscape.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
What is the Immune System?
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Cell Diversity
Multicellular...
Diversity of Archaea II
Diversity of Protists I

